Skip to content

Clinical trials

Phase 1 Intermittent Claudication trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intermittent Claudication Phase: Phase 1 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20061
20071
20121
20141
20171
20181
20191
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genovate Biotechnology Co., Ltd.,5
National Heart, Lung, and Blood Institute (NHLBI)4
Proteon Therapeutics2
Losordo, Douglas, M.D.1
Louis Messina1
MultiCare Health System Research Institute1
Purdue University1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intermittent Claudication16
Peripheral Arterial Disease15
Atherosclerosis3
Peripheral Vascular Diseases3
Cardiovascular Diseases2
Arterial Occlusive Diseases1
Arteriosclerosis1
Constriction, Pathologic1
Hyperthermia1
Vascular Calcification1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.